Administration of diosmin and hesperidin at both the doses did not counteract pathological changes in SOD or GPx—their serological activity remained reduced in comparison to NDM rats and was not elevated above the activity recorded for T1DM rats. This evidence concerns the gene SOD1 and type 1 diabetes mellitus.